What is China Biotech Services Holdings Price-to-Operating-Cash-Flow?
As of today (2024-06-01), China Biotech Services Holdings's share price is HK$0.335.
China Biotech Services Holdings's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.00. Hence, China Biotech Services Holdings's Price-to-Operating-Cash-Flow Ratio for today is .
The historical rank and industry rank for China Biotech Services Holdings's Price-to-Operating-Cash-Flow or its related term are showing as below:
HKSE:08037'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 0 Med: 0 Max: 47.62
Current: 1.66
During the past 13 years, China Biotech Services Holdings's highest Price-to-Operating-Cash-Flow Ratio was 47.62. The lowest was 0.00. And the median was 0.00.
China Biotech Services Holdings's Cash Flow from Operations per share for the
three
months ended in Dec. 2023 was HK$0.00.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.00.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of China Biotech Services Holdings was -59.50% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -22.50% per year.
During the past 13 years, China Biotech Services Holdings's highest 3-Year average Operating Cash Flow per Share Growth Rate was 61.10% per year. The lowest was -74.60% per year. And the median was 23.20% per year.
China Biotech Services Holdings Price-to-Operating-Cash-Flow Historical Data
The historical data trend for China Biotech Services Holdings's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Biotech Services Holdings Price-to-Operating-Cash-Flow Chart
|
China Biotech Services Holdings Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
- |
2.98 |
32.86 |
2.30 |
3.79 |
|
China Biotech Services Holdings Quarterly Data
|
|
Mar19 |
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
2.30 |
- |
- |
- |
3.79 |
Competitive Comparison of China Biotech Services Holdings's Price-to-Operating-Cash-Flow
For the Diagnostics & Research subindustry, China Biotech Services Holdings's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Biotech Services Holdings's Price-to-Operating-Cash-Flow Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, China Biotech Services Holdings's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where China Biotech Services Holdings's Price-to-Operating-Cash-Flow falls into.
China Biotech Services Holdings Price-to-Operating-Cash-Flow Calculation
China Biotech Services Holdings's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 0.335 | / | 0 |
| = | |
China Biotech Services Holdings's Share Price of today is HK$0.335.
China Biotech Services Holdings's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
China Biotech Services Holdings (HKSE:08037) Business Description
Traded in Other Exchanges
N/A
Address
255-257 Gloucester Roaad, Suites 1904-05A, 19th Floor, Sino Plaza, Causeway Bay, Hong Kong, HKG
China Biotech Services Holdings Ltd is an investment holding company. It operates through six segments: Pharmaceutical Products, Medical and Health-Related Services, Immunotherapy, Securities, Insurance brokerage, BNCT and Others. It derives prime revenue from the Medical and health related services segment which involves the provision of medical laboratory testing and health check services. The group has a business presence in Hong Kong and the PRC, of which key revenue is generated from Hong Kong.
Executives
China Biotech Services Holdings (HKSE:08037) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:08037 has been successfully added to your